Baby Brent’s Bill directs the Federal Trade Commission to investigate and regulate the deceptive marketing of preterm infant formula while ensuring families retain the right to seek legal recourse for harm caused by these products.
Chris Pappas
Representative
NH-1
Baby Brent’s Bill aims to protect preterm infants by ensuring families are fully informed about the health risks associated with preterm infant formula. The legislation directs the Federal Trade Commission (FTC) to investigate and regulate the marketing of these products to prevent deceptive practices. Additionally, the bill affirms the right of families to seek legal recourse if their infants are harmed by such products.
The Baby Brent’s Bill is a direct response to the devastating impact of necrotizing enterocolitis (NEC)—a life-threatening intestinal disease that claims the life of roughly one preterm infant every day. The legislation targets the way specialized formulas and 'fortifiers' (additives used to boost calories in milk) are sold to parents and hospitals. By empowering the Federal Trade Commission (FTC) to police the industry, the bill aims to ensure that the marketing materials for these products don't gloss over the potential risks or skip the fine print regarding the differences between cow-milk-based products and human-milk-based alternatives.
For parents sitting in a Neonatal Intensive Care Unit (NICU), the technical details of infant nutrition are the last thing they want to decode while under extreme stress. This bill requires the FTC to launch a massive investigation into whether formula manufacturers are being 'unfair or deceptive' in their advertising. Specifically, the FTC has one year to report on whether companies are failing to disclose health risks or hiding the benefits of human-milk-based fortifiers over bovine (cow) versions. It’s about making sure a tired parent or a busy nurse isn't being sold a product based on incomplete data when the stakes are literally life and death.
Once the investigation is wrapped up, the bill gives the FTC 18 months to roll out hard regulations. These won't just be suggestions; they will be legally binding rules that prohibit manufacturers from omitting critical health warnings. For the companies making these products, this means a total overhaul of their marketing playbooks. If they get caught cutting corners or failing to provide comparative information about feeding options, they’ll face the same heavy-duty penalties and enforcement actions the FTC uses to go after any other deceptive trade practice.
A key takeaway for families is the bill’s 'Sense of Congress' regarding legal rights. It explicitly states that no manufacturer should be able to limit or evade a family’s ability to seek compensation if their child is harmed by NEC. While this section is more of a policy stance than a new regulation, it sets a clear tone: the government intends to protect the legal standing of parents who believe their infants were put at risk by inadequate product disclosures. For the average family, this bill is designed to ensure that the information you get in the hospital is as transparent and accurate as possible, backed by the full weight of federal oversight.